Here's What to Expect From IDEXX Laboratories' Next Earnings Report

Westbrook, Maine-based IDEXX Laboratories, Inc. (IDXX) develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries. Valued at a market cap of $42.7 billion, the company also offers a range of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. It is scheduled to announce its fiscal Q2 earnings for 2025 before the market opens on Monday, Aug. 4.

Before this event, analysts project this pet healthcare company to report a profit of $3.29 per share, up 34.8% from $2.44 per share in the year-ago quarter. The company has surpassed Wall Street’s bottom-line estimates in three of the last four quarters, while missing on another occasion. Its earnings of $2.96 per share in the previous quarter topped the consensus estimates by 1.4%.